Whey Protein Shows Significant Improvement on Blood Pressure
Whey protein may have an influence on lowering blood pressure, according to research published in the upcoming November issue of International Dairy Journal.In a six-week controlled intervention, researchers at Washington State University tested the effects of daily consumption of 28 g of hydrolyzed or non-hydrolyzed whey protein beverages on young men and women.
Whey protein may have an influence on lowering blood pressure, according to research published in the upcoming November issue of International Dairy Journal.
In a six-week controlled intervention, researchers at Washington State University tested the effects of daily consumption of 28 g of hydrolyzed or non-hydrolyzed whey protein beverages on young men and women.
Systolic blood pressure (SBP), diastolic blood pressure (DBP), and mean arterial blood pressure (MAP) were measured.
Comparing hydrolyzed to non-hydrolyzed whey, no differences on influencing the above measures were noted; but the influence of both wheys on blood pressure markers was often significant. In subjects with elevated SBP and DBP, whey significantly decreased these measures. In subjects with high SBP only, whey significantly decreased this measure. For subjects with healthy blood pressure levels, SBP, DBP, and MAP remained unchanged after baseline.
Total and low-density lipoprotein (LDL or 'bad'ÃÂ cholesterol) was also lowered in subjects after whey consumption.
The results of this intervention left researchers to conclude that 'Whey protein beverages may be useful for the dietary treatment of prehypertension and/or stage 1 hypertension.'ÃÂ
To read the study abstract, click here.
Sirio Pharma launches line of ready-to-market organic gummies and softgels called PureOrganix
August 26th 2024The new line is made up of three gummies and one softgel that are formulated to meet stringent EU-Organic certification criteria, and target women’s health, metabolic health, and heart health.
SourceOne Global Partners to distribute Qualitas Health’s microalgae omega-3 ingredient globally
August 15th 2024SourceOne Global Partners has announced a partnership with Qualitas Health Inc., (dba iwi life) to introduce the company’s trademarked AlmegaPL microalgae omega-3 ingredient to the global marketplace.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
